OneSource Specialty Pharma Ltd reports consolidated Q4FY25 PAT of Rs. 98.50 crores

Onesource Specialty Pharma Limited has reported Consolidated financial results for the period ended March 31, 2025.

Financial Results (Q4 FY2025) - QoQ Comparison

The company has reported total income of Rs. 428.843 crores during the period ended March 31, 2025 as compared to Rs. 399.281 crores during the period ended December 31, 2024.

The company has posted net profit / (loss) of Rs. 98.502 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs. -68.849 crores for the period ended December 31, 2024.

The company has reported EPS of Rs. 8.59 for the period ended March 31, 2025 as compared to Rs. -6.31 for the period ended December 31, 2024.

Financials	Q4 FY2025	Q3 FY2025	% Change
Total Income	₹ 428.843 crs	₹399.281 crs	7.40%
Net Profit	₹98.502 crs	₹-68.849 crs	243.07%
EPS	₹8.59	₹-6.31	236.13%

Financial Results (Q4 FY2025) - YoY Comparison

The company has reported total income of Rs. 428.843 crores during the period ended March 31, 2025 as compared to Rs.75.779 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs.98.502 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs.-40.170 crores for the period ended March 31, 2024.

The company has reported EPS of Rs.8.59 for the period ended March 31, 2025 as compared to Rs.-9.67 for the period ended March 31, 2024.

Financials	Q4 FY2025	Q4 FY2024	% Change
Total Income	₹ 428.843 crs	₹75.779 crs	465.91%
Net Profit	₹98.502 crs	₹-40.170 crs	345.21%
EPS	₹8.59	₹-9.67	188.83%

Financial Results (Year Ended FY2025) - YoY Comparison

The company has reported total income of Rs.1462.327 crores during the Financial Year ended March 31, 2025 as compared to Rs.176.144 crores during the Financial Year ended March 31, 2024.

The company has posted net profit / (loss) of Rs.-17.971 crores for the Financial Year ended March 31, 2025 as against net profit / (loss) of Rs.-391.165 crores for the Financial Year ended March 31, 2024.

The company has reported EPS of Rs.-1.63 for the Financial Year ended March 31, 2025 as compared to Rs.-94.15 for the Financial Year ended March 31, 2024.

Financials	Year Ended FY2025	Year Ended FY2024	% Change
Total Income	₹1462.327 crs	₹176.144 crs	730.19%
Net Profit	₹-17.971 crs	₹-391.165 crs	95.41%
EPS	₹-1.63	₹-94.15	98.27%

Shares of Onesource Specialty Pharma Limited was last trading in BSE at Rs. 1658.55 as compared to the previous close of Rs. 1593.00. The total number of shares traded during the day was 4086 in over 656 trades.

The stock hit an intraday high of Rs. 1677.40 and intraday low of 1597.20. The net turnover during the day was Rs. 6677248.00.

Source : Equity Bulls

Keywords

OneSourceSpecialtyPharma Q4FY25 Q4FY2025 FY2025 ResultUpdate